Poliomyelitis Completed Phase 3 Trials for Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen (DB10990)

Also known as: Polio / Acute poliomyelitis, unspecified / Acute unspecified poliomyelitis / Polio acute / Acute poliomyelitis / Poliomyelitis NOS / Acute poliomyelitis (disorder) / Epidemic acute poliomyelitis (disorder) / Heine-Medin disease / Poliomyelitis (acute) / Poliomyelitis acute

IndicationStatusPhase
DBCOND0013769 (Poliomyelitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00879827
Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy InfantsPrevention
NCT01309646
Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib VaccinePrevention
NCT01457508
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered SeparatelyPrevention
NCT02096263
Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy InfantsPrevention